Beau Webber advances genome engineering in human immune cells, emphasizing non-viral integration, base editing, and transposon platforms for CAR-T/NK and gamma delta T cells. Co-developed EditR; funded work spans solid tumors and RDEB; provisional patents in gamma delta T-cell engineering.